BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10890355)

  • 1. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of secreted human immunodeficiency virus type 1 (HIV-1) resistance factors in CD4-positive T lymphocytes by attenuated HIV-1 infection.
    Simm M; Miller LS; Durkin HG; Allen M; Chao W; Lesner A; Potash MJ; Volsky DJ
    Virology; 2002 Mar; 294(1):1-12. PubMed ID: 11886260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.
    Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ
    J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages.
    Gabuzda DH; Li H; Lawrence K; Vasir BS; Crawford K; Langhoff E
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):908-15. PubMed ID: 7519673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.
    Madani N; Kabat D
    J Virol; 1998 Dec; 72(12):10251-5. PubMed ID: 9811770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.
    Wang J; Shackelford JM; Casella CR; Shivers DK; Rapaport EL; Liu B; Yu XF; Finkel TH
    Virology; 2007 Mar; 359(2):243-52. PubMed ID: 17056089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines.
    Hevey M; Donehower LA
    Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Sheehy AM; Gaddis NC; Choi JD; Malim MH
    Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
    Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B
    J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2.
    Dern K; Rübsamen-Waigmann H; Unger RE
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):295-309. PubMed ID: 11242517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions.
    Baraz L; Kotler M
    Curr Med Chem; 2004 Jan; 11(2):221-31. PubMed ID: 14754418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
    Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J
    J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.